As a new €2 million gene therapy research project funded by APC and Research Ireland is announced, we speak with the project lead Prof Niall Barron about its potential and how Ireland is positioning ...
lt;pgt;Scientists have successfully reconstructed a virus thousands of years after it became extinct, a development they believe could herald a new step in treating genetic diseases such as cystic ...
These findings highlight the potential of self-complementary AAVs to reduce dose requirements, minimize toxicity, and broaden ...
In cancer therapy research, scientists harness viruses and gene transfer to trigger immune-driven tumor destruction, offering hope against hard-to-treat melanoma. Study: A virus based vaccine combined ...
Viral vectors dominate gene therapy, with lentivirus, adenovirus, and AAV being key players, each with unique advantages and limitations. Non-viral vectors, such as lipid nanoparticles and GalNAc, ...
Despite the best efforts of modern medicine, Huntington’s disease is a condition that still comes with a tragic prognosis. Primarily an inherited disease, its main symptoms concern ...
In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...
Some of the most expensive drugs currently in use are gene therapies to treat specific diseases, and their high cost limits ...
A team led by University of Pittsburgh's Graham Hatfull has developed a method to construct bacteriophages with entirely ...
AUSTIN, Texas, June 23, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback